Jianhui Ma

机构：Zhoukou Normal University, Zhoukou City Academy of Agricultural Sciences

发表论文 69 篇 · 总被引 781 次 · h-index 14

代表论文

• Anlotinib for Patients With Metastatic Renal Cell Carcinoma Previously Treated With One Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor: A Phase 2 Trial (2020 · Frontiers in Oncology · 被引 33)
• Prognostic Significance of NLR About NETosis and Lymphocytes Perturbations in Localized Renal Cell Carcinoma With Tumor Thrombus (2021 · Frontiers in Oncology · 被引 22)
• Copy Number Variations of CEP63, FOSL2 and PAQR6 Serve as Novel Signatures for the Prognosis of Bladder Cancer (2021 · Frontiers in Oncology · 被引 18)
• Neoadjuvant Chemotherapy–Guided Bladder-Sparing Treatment for Muscle-Invasive Bladder Cancer: Results of a Pilot Phase II Study (2021 · Cancer Research and Treatment · 被引 18)
• <p>miR-105 Promotes the Progression and Predicts the Prognosis for Oral Squamous Cell Carcinoma (OSCC)</p> (2020 · Cancer Management and Research · 被引 14)
• Radium‐223 in Asian patients with castration‐resistant prostate cancer with symptomatic bone metastases: A single‐arm phase 3 study (2020 · Asia-Pacific Journal of Clinical Oncology · 被引 11)